In September 2026, the National Medical Products Administration (NMPA) announced that a flight inspection of one enterprise had revealed serious defects in its production quality management system. The medical products administrations of Fujian and Jiangxi provinces successively issued announcements on cosmetics supervision sampling inspections, with a total of 10 batches of cosmetics found non-compliant.
CIRS Group has now compiled and summarized the September sampling data and regulatory updates, so as to help enterprises keep abreast of market supervision trends and screen for compliance risks in advance.
NMPA Cosmetics Supervision Sampling Data
NMPA Announcement on the Flight Inspection Results of Gansu Jiujianpeng Jinyinhua Technology Co., Ltd. (No. 31 of 2026)
On September 14, 2026, the NMPA released the announcement that it had recently organized a flight inspection of Gansu Jiujianpeng Jinyinhua Technology Co., Ltd. The inspection found that the enterprise had violated the Cosmetics Supervision and Administration Regulation, the Cosmetics Good Manufacturing Practice (GMP), and other relevant provisions, with serious defects existing in its production quality management system. To safeguard the safety of cosmetic use by the public, the NMPA required the Gansu Medical Products Administration to investigate and deal with the enterprise's suspected illegal acts in accordance with the law. At present, the Gansu Medical Products Administration has opened a case for investigation against the enterprise, and has ordered it to suspend production and trading operations and to rectify the identified problems.
Local Medical Products Administrations' Cosmetics Supervision Sampling Data
Announcement on the Results of Cosmetic Sampling Inspections in Fujian Province (Issue No. 2 of 2026)
On September 14, 2026, the Fujian Medical Products Administration released the results of the 2026 Issue No. 2 cosmetic sampling inspections. The sampling inspection found 1 batch of body lotion non-compliant, with the non-compliant items being excessive total bacterial count and excessive total count of molds and yeasts.
Announcement by the Jiangxi Medical Products Administration on Cosmetics Supervision Sampling Information (Issue No. 2 of 2026)
On September 18, 2026, the Jiangxi Medical Products Administration released the results of the 2026 Issue No. 2 cosmetics supervision sampling inspections, with 9 batches of products found non-compliant in this issue. The non-compliant products included whitening and spot-fading creams, hair dye creams, face creams, body washes, shampoos, face masks, and bath soap liquids, etc. The non-compliant items included excessive contents of salicylic acid and HC Yellow No. 2; the detection of the prohibited ingredient clobetasol propionate; and excessive total bacterial count and excessive total count of molds and yeasts, etc. The manufacturers of two of the rinse-off products denied having produced the products concerned.
Regulatory Updates
Publication of Information on Non-Compliant Cosmetics in the 2026 Annual District-Level Sampling Inspection of Wuqing District, Tianjin
On September 7, 2026, the Administration for Market Regulation of Wuqing District, Tianjin publicized the results of the 2026 annual cosmetics supervision sampling inspection. The administration conducted supervision sampling on cosmetics at the distribution stage within its jurisdiction, randomly sampling 10 batches of products in total, among which 2 batches of moisturizing products were found non-compliant. The non-compliant items were: the detection of the prohibited colorant Sudan I; and excessive total bacterial count and excessive total count of molds and yeasts, respectively.
The Administration for Market Regulation of Xiamen Conducts the Second 'Double Random' Spot Inspection of Cosmetics Distribution in 2026
On September 18, 2026, the Administration for Market Regulation of Xiamen, Fujian announced that it would organize the second 'double random' spot inspection of cosmetics distribution and use in 2026 from September 17 to October 30, targeting cosmetics distribution and use entities across the city, which are randomly selected at a ratio of 2%. The spot inspection is conducted in accordance with the Cosmetics Supervision and Administration Regulation and other regulatory documents, focusing on the fulfillment of primary responsibilities by distribution and use entities, their business practices, the products distributed, risk disposal, e-commerce business obligations, etc.
The Administration for Market Regulation of Putuo District, Shanghai Publishes Administrative Inspection Information on Cosmetics Distribution Enterprises (September 2026)
On September 30, 2026, the Administration for Market Regulation of Putuo District, Shanghai released the announcement on the administrative inspection information of cosmetics distribution enterprises for September 2026. The administrative inspection conclusions are classified into three categories: qualified, non-qualified, and rectification within a prescribed time limit. A total of 66 enterprises were inspected, including: 0 non-qualified enterprises, 9 enterprises required to rectify within a prescribed time limit, 0 enterprises that had suspended business, 8 untraceable enterprises, and 49 qualified enterprises.
CIRS Reminder
The results of cosmetics regulatory sampling inspections across many regions of China in September 2026 show that problems such as excessive microbial content, illegal addition of prohibited ingredients, and non-compliant contents of restricted ingredients are relatively concentrated. Meanwhile, problems such as inadequate implementation of compliance management by business operators still exist in the market.
CIRS hereby reminds relevant enterprises to keep a close eye on industry regulatory trends, carry out raw material control and formula review against the typical problems identified in sampling inspections, and screen for potential compliance risks in a timely manner. Enterprises should strictly abide by the Cosmetics Supervision and Administration Regulation and relevant technical standards, so as to avoid quality problems and compliance risks at the source and comprehensively build a solid bottom line of quality safety and compliance.
If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.
Our Services
- China Cosmetics Registration and Filing
- China New Cosmetic Ingredients Registration and Filing
- China Toothpaste Filing
- China Cosmetics Safety and Efficacy Test
- Being Domestic Responsible Person
- Safety Evaluation Report
- Cosmetic Ingredient Quality and Safety Info Code Application
- Formula/Label/Ingredient Review
- Regulatory Consulting/Reporting/Training
- Custom Clearance
